INJEX Pharma AG

INJEX Pharma AG to Bring Needle-free Injection System to US

The company has received approval from the FDA to sell its needle-free product in America.

INJEX Pharma AG receives FDA clearance for the import and sale of the needle free injection technology INJEX 30 into the US Market

The FDA had registered INJEX Pharma GmbH, Berlin, and INJEX Pharma US, Miami, and given approval for the import and sale of INJEX 30 in the US market. The condition was the registration by the FDA for INJEX Pharma GmbH as manufacturer and exporter. This registration is now finalized.

No votes yet
Syndicate content